Status:
UNKNOWN
Insulin Stimulated Vasodilation in Patients With Type 2 Diabetes
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
The University of Texas at Arlington
Conditions:
Type2 Diabetes
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
This study evaluates the role of endothelin in insulin stimulated vasodilation and glucose uptake. The subjects will complete an hyperinsulinemic euglycemic clamp with and without blockade of the endo...
Eligibility Criteria
Inclusion
- Type 2 diabetes OR healthy control (no type 2 diabetes)
- BMI\<32
Exclusion
- heart disease
- pregnancy or birth within 3 month
- smoking
- Kidney disease
- beta-blockers
- insulin treatment (for type 2 diabetics)
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04907838
Start Date
May 1 2018
End Date
July 30 2021
Last Update
June 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular and Renal Research
Odense, Denmark, 5000